Joel W. Neal

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 61 papers. Top paper: “A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors”.

A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors

Cancer Discovery(2013)10.1158/2159-8290.cd-13-0183

N/A

0.885DataRank · unranked

364 citations

Joel T. Dudley, Pawel K. Mazur, Natasha Flores, Dian Yang, Alec Palmerton +15 more

KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0282

N/A

0.775DataRank · unranked

174 citations

Young-Jun Jeon, Monica Nesselbush, Everett J. Moding, Barzin Y. Nabet, Diego Almanza +26 more

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

Nature(2024)10.1038/s41586-024-07943-7

N/A

0.769DataRank · unranked

168 citations

Haniel A. Araújo, Minh Truong, Yu Qian, Xin Sun, Ana Galán‐Cobo +95 more

Durvalumab for Stage III EGFR-Mutated NSCLC After Definitive Chemoradiotherapy

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.01.1628

N/A

0.731DataRank · unranked

130 citations

Isa Mambetsariev, Jessica A. Hellyer, Arya Amini, Joel W. Neal, Sukhmani K. Padda +11 more

Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLC

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3418

N/A

0.723DataRank · unranked

123 citations

Barzin Y. Nabet, Hira Rizvi, Aadel A. Chaudhuri, Daniel K. Wells, Mark Dunphy +30 more

Myocarditis Surveillance With High-Sensitivity Troponin I During Cancer Treatment With Immune Checkpoint Inhibitors

JACC CardioOncology(2021)10.1016/j.jaccao.2021.01.004

N/A

0.721DataRank · unranked

121 citations

Joel W. Neal, Sunil Reddy, Heather A. Wakelee, Sumit Shah, Sandy Srinivas +7 more

Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study

The Lancet Digital Health(2023)10.1016/s2589-7500(23)00082-1

N/A

0.708DataRank · unranked

111 citations

Lingzhi Hong, Muhammad Aminu, Natalie I. Vokes, Pingjun Chen, Morteza Salehjahromi +44 more

Radiological tumour classification across imaging modality and histology

Nature Machine Intelligence(2021)10.1038/s42256-021-00377-0

N/A

0.685DataRank · unranked

95 citations

Chao Li, Michael F. Gensheimer, Sukhmani K. Padda, Fumi Kato, Hiroki Shirato +11 more

Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study

Journal of Thoracic Oncology(2024)10.1016/j.jtho.2024.01.012

N/A

0.571DataRank · unranked

44 citations

So Yeon Kim, Jacqueline V. Aredo, Jamie Feng, Frances A. Shepherd, Chao Xu +52 more

Efficacy of Osimertinib in Patients with Lung Cancer Positive for Uncommon EGFR Exon 19 Deletion Mutations

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3497

N/A

0.564DataRank · unranked

42 citations

Jacqueline V. Aredo, Jacqueline H. Starrett, Paul Stockhammer, Iris K. van Alderwerelt van Rosenburgh, Anna Wurtz +16 more

AI-enabled virtual spatial proteomics from histopathology for interpretable biomarker discovery in lung cancer

Nature Medicine(2026)10.1038/s41591-025-04060-4

N/A

0.561DataRank · unranked

41 citations

Yuchen Li, Jinxi Xiang, Xiyue Wang, Sen Yang, Xiaoming Zhang +15 more

The Survival Impact of Second Primary Lung Cancer in Patients With Lung Cancer

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab224

N/A

0.489DataRank · unranked

25 citations

Sophia J. Luo, Jacqueline V. Aredo, Leah M. Backhus, Lynne R. Wilkens, Chloe C. Su +6 more

Cardiac Troponin Screening and Clinical Outcomes in Patients Receiving Immunotherapy

JACC CardioOncology(2025)10.1016/j.jaccao.2025.06.009

N/A

0.385DataRank · unranked

12 citations

Maja Ivanovic, Antonia Chan, Sidra Xu, Miguel Franquiz, Carissa Lee +19 more

Predictive Model to Guide Brain Magnetic Resonance Imaging Surveillance in Patients With Metastatic Lung Cancer: Impact on Real-World Outcomes

JCO Precision Oncology(2022)10.1200/po.22.00220

N/A

0.360DataRank · unranked

10 citations

Victoria Y. Ding, Sophia Luo, Eunji Choi, Jessica Hellyer, Nathaniel Myall +10 more

Risk model‐based management for second primary lung cancer among lung cancer survivors through a validated risk prediction model

Cancer(2023)10.1002/cncr.35069

N/A

0.345DataRank · unranked

9 citations

Sophia J. Luo, Victoria Y. Ding, Julie Wu, Ashok V. Kumar, Jason A. Wampfler +15 more

Cigarette and Alternative Tobacco Product Use among Adult Cancer Survivors Enrolled in 9 ECOG-ACRIN Clinical Trials

Cancer Epidemiology Biomarkers & Prevention(2023)10.1158/1055-9965.epi-23-0420

N/A

0.345DataRank · unranked

9 citations

Ju‐Whei Lee, Angela Wangari Walter, Rachel Rosen, Ilana F. Gareen, Sheetal Mehta Kircher +17 more

The evolving landscape of leptomeningeal metastases from NSCLC: an international, contemporary, multicenter cohort study

Annals of Oncology(2025)10.1016/j.annonc.2025.09.140

N/A

0.345DataRank · unranked

9 citations

Y. Xia, Ke Pan, Fangdi Sun, Aaron C. Tan, Xinran Dong +31 more

Safety and Tolerability of Letetresgene Autoleucel (GSK3377794): Pilot Studies in Patients with Advanced Non–Small Cell Lung Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1591

N/A

0.292DataRank · unranked

6 citations

Gilberto Lopes, T. Jeroen N. Hiltermann, Ramaswamy Govindan, Liza C. Villaruz, Emiliano Calvo +19 more

Molecular Characteristics and Pretreatment Neutrophil-to-Lymphocyte Ratio as Predictors of Durable Clinical Benefit from Immune Checkpoint Inhibition in Non-Small Cell Lung Cancer

Clinical Lung Cancer(2024)10.1016/j.cllc.2024.06.006

N/A

0.292DataRank · unranked

6 citations

Isabelle Blanchard, Sukhmani K. Padda, Heather A. Wakelee, Joel W. Neal, Arpeet T. Shah

Cabozantinib after prior checkpoint inhibitor therapy in patients with solid tumors: A systematic literature review

Cancer Treatment Reviews(2022)10.1016/j.ctrv.2022.102453

N/A

0.292DataRank · unranked

6 citations

Arndt Vogel, Ann-Lii Cheng, Georg A. Bjarnason, Joel W. Neal, Jeffrey Graham

Neighborhood socioeconomic disadvantage, tobacco use, and cessation indicators among adults with cancer in the United States: Results from 10 ECOG-ACRIN trials.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.6514

N/A

0.189DataRank · unranked

2 citations

Ju‐Whei Lee, Ilana F. Gareen, Sheetal Kircher, B. Herman, Joanna M. Streck +14 more

KEAP1/NFE2L2 mutations to predict local recurrence after radiotherapy but not surgery in localized non-small cell lung cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9012

N/A

0.104DataRank · unranked

1 citations

Young-Jun Jeon, Monica Nesselbush, Everett J. Moding, Barzin Y. Nabet, Diego Almanza +15 more

A mid-chemoradiation dynamic risk model integrating tumor features and ctDNA analysis for lung cancer outcome prediction.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9046

N/A

0.104DataRank · unranked

1 citations

Mohammad Shahrokh Esfahani, Barzin Y. Nabet, Yufei Liu, Jacob J. Chabon, Jianzhong He +15 more

Supplementary Table S1 from A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors

Figshare(2023)10.1158/2159-8290.22528325.v1

N/A

0DataRank · unranked

0 citations

Joel T. Dudley, Pawel K. Mazur, Natasha Flores, Dian Yang, Alec Palmerton +15 more

Combining Osimertinib With Chemotherapy in EGFR-Mutant NSCLC at Progression

Clinical Lung Cancer(2021)10.1016/j.cllc.2021.01.010

N/A

0DataRank · unranked

42 citations

Zofia Piotrowska, Kevin Stirling, Stephen V. Liu, Mandeep K. Banwait, Kristen Cunanan +5 more

Supplementary Figure S1 from A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors

(2023)10.1158/2159-8290.22528352

N/A

0DataRank · unranked

0 citations

Joel T. Dudley, Pawel K. Mazur, Natasha Flores, Dian Yang, Alec Palmerton +15 more

The Role of Single-Cell Profiling and Deep Immunophenotyping in Understanding Immune Therapy Cardiotoxicity

JACC CardioOncology(2022)10.1016/j.jaccao.2022.08.012

N/A

0DataRank · unranked

12 citations

Sarah Waliany, Daniel Lee, Francisco X. Galdos, Ronald Witteles, Joel W. Neal +6 more

Representativeness of patients enrolled in the Lung Cancer Master Protocol (Lung-MAP).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.6543

N/A

0DataRank · unranked

0 citations

Joseph M. Unger, Qian Lü, Katherine Minichiello, Roy S. Herbst, David R. Gandara +14 more

Efficacy of osimertinib in patients with EGFR mutant lung cancer harboring the uncommon exon 19 deletion, L747_A750>P.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e21112

N/A

0DataRank · unranked

0 citations

Jacqueline V. Aredo, Jacqueline H. Starrett, Anna Wurtz, Zofia Piotrowska, Andrew J. Piper‐Vallillo +13 more

Supplementary Table S1 from A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors

(2023)10.1158/2159-8290.22528325

N/A

0DataRank · unranked

0 citations

Joel T. Dudley, Pawel K. Mazur, Natasha Flores, Dian Yang, Alec Palmerton +15 more

Supplementary Figure S3 from A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors

INDIGO (University of Illinois at Chicago)(2023)10.1158/2159-8290.22528346.v1

N/A

0DataRank · unranked

0 citations

Joel T. Dudley, Pawel K. Mazur, Natasha Flores, Dian Yang, Alec Palmerton +15 more

Immunotherapy-Associated Atherosclerosis: A Comprehensive Review of Recent Findings and Implications for Future Research

Current Treatment Options in Cardiovascular Medicine(2023)10.1007/s11936-023-01024-0

N/A

0DataRank · unranked

15 citations

Stefan Torelli, Evaline Cheng, Ryan Batchelder, Sarah Waliany, Joel W. Neal +5 more

Overall Survival Among Patients With De Novo Stage IV Metastatic and Distant Metastatic Recurrent Non–Small Cell Lung Cancer

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.35813

N/A

0DataRank · unranked

12 citations

Julie Wu, Eunji Choi, Nathaniel J. Myall, Joel W. Neal, Allison W. Kurian +8 more

Phenotyping EMT and MET cellular states in lung cancer patient liquid biopsies at a personalized level using mass cytometry

Scientific Reports(2023)10.1038/s41598-023-46458-5

N/A

0DataRank · unranked

11 citations

Danny Pancirer, Jordan S. Preiss, Jalen Benson, Winston Trope, Joseph B. Shrager +6 more

Supplementary Figure S5 from A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors

(2023)10.1158/2159-8290.22528337

N/A

0DataRank · unranked

0 citations

Joel T. Dudley, Pawel K. Mazur, Natasha Flores, Dian Yang, Alec Palmerton +15 more

Osimertinib-Associated Cardiomyopathy In Patients With Non-Small Cell Lung Cancer

JACC CardioOncology(2023)10.1016/j.jaccao.2023.07.006

N/A

0DataRank · unranked

8 citations

Sarah Waliany, Audrey Xu, Anna P. Hnatiuk, Sean M. Wu, Paul Cheng +5 more

Supplementary Figure S4 from A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors

(2023)10.1158/2159-8290.22528343

N/A

0DataRank · unranked

0 citations

Joel T. Dudley, Pawel K. Mazur, Natasha Flores, Dian Yang, Alec Palmerton +15 more

The effect of ctDNA tumor fraction (TF) on overall survival and concordance between tissue genomics and ctDNA in Lung-MAP.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.9035

N/A

0DataRank · unranked

0 citations

Mary W. Redman, David Kozono, Sam Callis, Hanna Tukachinsky, Khaled Tolba +14 more

CNS Control after First-Line Osimertinib in Patients with Metastatic EGFR-Mutant NSCLC

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.06.888

N/A

0DataRank · unranked

0 citations

Heather A. Wakelee, Joel W. Neal, Kavitha Ramchandran, Millie Das, Seema Nagpal +5 more

Data from A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors

(2023)10.1158/2159-8290.c.6545696.v1

N/A

0DataRank · unranked

0 citations

Joel T. Dudley, Pawel K. Mazur, Natasha Flores, Dian Yang, Alec Palmerton +15 more

Supplementary Figure S2 from A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors

(2023)10.1158/2159-8290.22528349

N/A

0DataRank · unranked

0 citations

Joel T. Dudley, Pawel K. Mazur, Natasha Flores, Dian Yang, Alec Palmerton +15 more

Supplementary Figure S5 from A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors

(2023)10.1158/2159-8290.22528337.v1

N/A

0DataRank · unranked

0 citations

Joel T. Dudley, Pawel K. Mazur, Natasha Flores, Dian Yang, Alec Palmerton +15 more

Smoking and the Risk of Second Primary Lung Cancer Among Breast Cancer Survivors from the Population-Based UK Biobank Study

Clinical Lung Cancer(2024)10.1016/j.cllc.2024.08.017

N/A

0DataRank · unranked

5 citations

Eunji Choi, Julie Wu, Timothy Ellis-Caleo, Joel W. Neal, Heather A. Wakelee +3 more

Supplementary Methods from A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors

(2023)10.1158/2159-8290.22528328

N/A

0DataRank · unranked

0 citations

Joel T. Dudley, Pawel K. Mazur, Natasha Flores, Dian Yang, Alec Palmerton +15 more

Racial and ethnic differences in second primary lung cancer risk among lung cancer survivors

JNCI Cancer Spectrum(2024)10.1093/jncics/pkae072

N/A

0DataRank · unranked

2 citations

Yue Hua, Chloe C. Su, Julie Wu, Joel W. Neal, Ann N. Leung +8 more

A Novel Therapeutic Approach using CXCR3 Blockade to Treat Immune Checkpoint Inhibitor-mediated Myocarditis

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.01.30.576279

N/A

0DataRank · unranked

5 citations

Daniel Lee, Yin Sun, Harrison Chou, Bruce Xu, Zachary Lin +13 more

THE IMPACT OF ROUTINE CARDIAC TROPONIN I-BASED CARDIOTOXICITY SCREENING ON CLINICAL OUTCOMES IN PATIENTS ON CANCER IMMUNOTHERAPY

medRxiv(2024)10.1101/2024.01.22.24301442

N/A

0DataRank · unranked

4 citations

Antonia Chan, Evaline Cheng, Sidra Xu, Carissa Lee, Jonathan You +17 more

Supplementary Figure S2 from A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors

INDIGO (University of Illinois at Chicago)(2023)10.1158/2159-8290.22528349.v1

N/A

0DataRank · unranked

0 citations

Joel T. Dudley, Pawel K. Mazur, Natasha Flores, Dian Yang, Alec Palmerton +15 more

Data from A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors

(2023)10.1158/2159-8290.c.6545696

N/A

0DataRank · unranked

0 citations

Joel T. Dudley, Pawel K. Mazur, Natasha Flores, Dian Yang, Alec Palmerton +15 more

Leveraging large language models to extract smoking history from clinical notes for lung cancer surveillance

npj Digital Medicine(2025)10.1038/s41746-025-02009-y

N/A

0DataRank · unranked

4 citations

Anna Graber‐Naidich, Mengrui Zhang, Rakshit Kaushik, Grant M. Nieda, Tony Chen +22 more

Eligibility and Prognostic Performance of Smoking Duration–Based Versus Pack-Year–Based U.S. National Lung Cancer Screening Criteria Across Racial and Ethnic Groups

Annals of Internal Medicine(2025)10.7326/annals-25-00464

N/A

0DataRank · unranked

2 citations

Victoria Y. Ding, Kevin ten Haaf, Julie Wu, Neal D. Freedman, Leah M. Backhus +13 more

Napsin A-specific T cell clonotypes are associated with improved clinical outcomes in patients receiving checkpoint immunotherapy for metastatic non-small cell lung cancer

medRxiv(2025)10.1101/2025.03.10.25323586

N/A

0DataRank · unranked

0 citations

Christina S. Baik, Joel W. Neal, Fangdi Sun, Rafael Santana-Dávila, Sylvia Lee +13 more

Central Nervous System Progression in Patients Receiving ALK-Targeted Central Nervous System–Penetrable Tyrosine Kinase Inhibitors: Treatment Patterns and Outcomes

JTO Clinical and Research Reports(2025)10.1016/j.jtocrr.2025.100914

N/A

0DataRank · unranked

0 citations

Caressa Hui, Joel W. Neal, Seema Nagpal, Mohana Roy, Millie Das +6 more

Targeting BRAF Class II and III Mutations in NSCLC with the pan-RAF inhibitor Exarafenib Reveals ARAF-KSR1-Mediated Resistance and Rational Combination Strategies

Research Square(2025)10.21203/rs.3.rs-5135027/v1

N/A

0DataRank · unranked

0 citations

Tadashi Manabe, Hannah C. Bergo, Qingtian Li, Tim Sen Wang, Paul Severson +19 more

The effect of neighborhood socioeconomic disadvantage on smoking status, quit attempts, and receipt of cessation support among adults with cancer: Results from nine ECOG‐ACRIN Cancer Research Group trials

UNC Libraries(2025)10.17615/c1xc-d466

N/A

0DataRank · unranked

0 citations

Ju‐Whei Lee, Sheetal Mehta Kircher, Lynne I. Wagner, Frank S. Hodi, Jamie S. Ostroff +16 more

Supplementary Figure S3 from A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors

(2023)10.1158/2159-8290.22528346

N/A

0DataRank · unranked

0 citations

Joel T. Dudley, Pawel K. Mazur, Natasha Flores, Dian Yang, Alec Palmerton +15 more

Supplementary Figure S1 from A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors

INDIGO (University of Illinois at Chicago)(2023)10.1158/2159-8290.22528352.v1

N/A

0DataRank · unranked

0 citations

Joel T. Dudley, Pawel K. Mazur, Natasha Flores, Dian Yang, Alec Palmerton +15 more

A PHASE IIA STUDY REPOSITIONING DESIPRAMINE IN SMALL CELL LUNG CANCER AND OTHER HIGH-GRADE NEUROENDOCRINE TUMORS

Cancer Treatment and Research Communications(2020)10.1016/j.ctarc.2020.100174

N/A

0DataRank · unranked

14 citations

Nadine S. Jahchan, Millie Das, Michael Zach Koontz, Pamela L. Kunz, Heather A. Wakelee +4 more

Immune Checkpoint Inhibitor Cardiotoxicity: Understanding Basic Mechanisms and Clinical Characteristics and Finding a Cure

The Annual Review of Pharmacology and Toxicology(2020)10.1146/annurev-pharmtox-010919-023451

N/A

0DataRank · unranked

74 citations

Daniel Lee, Ronald Witteles, Joel W. Neal, Patricia K. Nguyen, Mark M. Davis +5 more

Supplementary Methods from A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors

INDIGO (University of Illinois at Chicago)(2023)10.1158/2159-8290.22528328.v1

N/A

0DataRank · unranked

0 citations

Joel T. Dudley, Pawel K. Mazur, Natasha Flores, Dian Yang, Alec Palmerton +15 more

Supplementary Figure S7 from A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors

INDIGO (University of Illinois at Chicago)(2023)10.1158/2159-8290.22528331.v1

N/A

0DataRank · unranked

0 citations

Joel T. Dudley, Pawel K. Mazur, Natasha Flores, Dian Yang, Alec Palmerton +15 more